Kling Bio has entered a partnership and licence option agreement with Sanofi to discover neutralising antibodies and epitopes. The partnership will leverage Kling Bio's screening platform, ...
Researchers in the United States have identified antibody-inducing epitopes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals vaccinated against coronavirus disease 2019 ...
The rapid development and rollout of effective vaccines to the global population are key measures to help arrest the ongoing coronavirus disease 2019 (COVID-19) pandemic. The current pandemic has been ...
The emergence and rapid propagation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants — in particular, the B.1.1.529 (omicron) sublineages, which have mutations that increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback